How do I compare CPC and SSA on lead time to the United Kingdom?

Stated plainly: CPC · SSA · the United Kingdom.

These are treated as interchangeable and I do not think they are.

If both are acceptable I would like to know that, so I can stop thinking about it.

What is the actual trade-off, and does it matter at the scale I am working at?

The honest answer is that most claimed differences between reputable suppliers are inside inter-laboratory noise.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

Certificate red flags and what each implies

Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.

The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.

Compare content, not purity. Purity clusters and content does not.

Answer first: comparing suppliers is only meaningful if the comparison holds the laboratory, the method and the compound constant, and most published comparisons hold none of them.

Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

To be exact about it, publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

Name the laboratory and the dates or the comparison cannot be reproduced.

Answering this needs the axis. A supplier that is best on paperwork and a supplier that is best on price are both correct answers to different questions.

Content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.

Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

Gradient slope, column chemistry and detection wavelength all affect the reported purity figure, which is why the method section is the part that makes results comparable.

Use a fixed documentation checklist rather than an impression.

Worth being precise here: ratings on this site are ours alone and are deliberately not reconciled with anyone else's.

Lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.

Comparisons drawn from different laboratories at different times are weaker evidence than most people treat them as.

Price per milligram of measured peptide, not per milligram of label claim.